Cargando…
Osteopontin predicts clinical outcome in patients after treatment of severe aortic stenosis with transcatheter aortic valve implantation (TAVI)
OBJECTIVE: Osteopontin (OPN) is an extracellular matrix protein that plays an integral role in myocardial remodelling and has previously been shown to be a valuable biomarker in cardiovascular disease. Because of the concentric myocardial hypertrophy associated with severe, symptomatic aortic stenos...
Autores principales: | Lutz, Matthias, von Ingersleben, Nora, Lambers, Moritz, Rosenberg, Mark, Freitag-Wolf, Sandra, Dempfle, Astrid, Lutter, Georg, Frank, Johanne, Bramlage, Peter, Frey, Norbert, Frank, Derk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5515168/ https://www.ncbi.nlm.nih.gov/pubmed/28761684 http://dx.doi.org/10.1136/openhrt-2017-000633 |
Ejemplares similares
-
Trial protocol for the validation of the ‘Toronto Aortic Stenosis Quality of Life (TASQ) Questionnaire’ in patients undergoing surgical aortic valve replacement (SAVR) or transfemoral (TF) transcatheter aortic valve implantation (TAVI): the TASQ registry
por: Frank, Derk, et al.
Publicado: (2019) -
Impact of preprocedural mitral regurgitation upon mortality after transcatheter aortic valve implantation (TAVI) for severe aortic stenosis
por: Khawaja, M Z, et al.
Publicado: (2014) -
Management of patients with severe aortic stenosis in the TAVI-era: how recent recommendations are translated into clinical practice
por: Lauten, Alexander, et al.
Publicado: (2021) -
Risk prediction in patients with low-flow, low-gradient aortic stenosis and reduced ejection fraction undergoing TAVI
por: Ludwig, Sebastian, et al.
Publicado: (2022) -
Quality of life after transcatheter or surgical aortic valve replacement using the Toronto Aortic Stenosis Quality of Life Questionnaire
por: Kennon, Simon, et al.
Publicado: (2021)